Based on the analysis of Embecta Corp's profitability, liquidity, and operating efficiency, Embecta Corp may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter. At present, Embecta Corp's Non Currrent Assets Other are projected to increase significantly based on the last few years of reporting. The current year's Other Assets is expected to grow to about 107.7 M, whereas Total Assets are forecasted to decline to about 1.1 B. Key indicators impacting Embecta Corp's financial strength include:
Investors should never underestimate Embecta Corp's ability to pay suppliers on time, ensure interest payments are not accumulating, and correctly time where and how to reinvest extra cash. Individual investors need to monitor Embecta Corp's cash flow, debt, and profitability to make informed and accurate decisions about investing in Embecta Corp.
Net Income
66.95 Million
Embecta
Select Account or Indicator
Market Cap
Enterprise Value
Price To Sales Ratio
Dividend Yield
Ptb Ratio
Days Sales Outstanding
Book Value Per Share
Free Cash Flow Yield
Operating Cash Flow Per Share
Stock Based Compensation To Revenue
Capex To Depreciation
Pb Ratio
Ev To Sales
Free Cash Flow Per Share
Roic
Inventory Turnover
Net Income Per Share
Days Of Inventory On Hand
Payables Turnover
Research And Ddevelopement To Revenue
Capex To Revenue
Cash Per Share
Pocfratio
Interest Coverage
Payout Ratio
Capex To Operating Cash Flow
Pfcf Ratio
Days Payables Outstanding
Income Quality
Roe
Ev To Operating Cash Flow
Pe Ratio
Return On Tangible Assets
Ev To Free Cash Flow
Earnings Yield
Intangibles To Total Assets
Net Debt To E B I T D A
Current Ratio
Tangible Book Value Per Share
Receivables Turnover
Shareholders Equity Per Share
Debt To Equity
Capex Per Share
Graham Net Net
Revenue Per Share
Interest Debt Per Share
Debt To Assets
Enterprise Value Over E B I T D A
Graham Number
Short Term Coverage Ratios
Price Earnings Ratio
Operating Cycle
Price Book Value Ratio
Price Earnings To Growth Ratio
Days Of Payables Outstanding
Dividend Payout Ratio
Price To Operating Cash Flows Ratio
Price To Free Cash Flows Ratio
Pretax Profit Margin
Ebt Per Ebit
Operating Profit Margin
Effective Tax Rate
Company Equity Multiplier
Long Term Debt To Capitalization
Total Debt To Capitalization
Return On Capital Employed
Debt Equity Ratio
Ebit Per Revenue
Quick Ratio
Dividend Paid And Capex Coverage Ratio
Net Income Per E B T
Cash Ratio
Cash Conversion Cycle
Operating Cash Flow Sales Ratio
Days Of Inventory Outstanding
Days Of Sales Outstanding
Free Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage Ratios
Price To Book Ratio
Fixed Asset Turnover
Capital Expenditure Coverage Ratio
Price Cash Flow Ratio
Enterprise Value Multiple
Debt Ratio
Cash Flow To Debt Ratio
Price Sales Ratio
Return On Assets
Asset Turnover
Net Profit Margin
Gross Profit Margin
Price Fair Value
Return On Equity
Change To Inventory
Investments
Change In Cash
Stock Based Compensation
Free Cash Flow
Change In Working Capital
Begin Period Cash Flow
Total Cashflows From Investing Activities
Other Cashflows From Financing Activities
Depreciation
Other Non Cash Items
Dividends Paid
Capital Expenditures
Total Cash From Operating Activities
Change To Account Receivables
Change To Operating Activities
Net Income
Total Cash From Financing Activities
End Period Cash Flow
Change To Netincome
Change To Liabilities
Total Assets
Other Current Liab
Total Current Liabilities
Total Stockholder Equity
Other Liab
Net Tangible Assets
Property Plant And Equipment Net
Accounts Payable
Non Current Assets Total
Non Currrent Assets Other
Other Assets
Net Receivables
Good Will
Common Stock Shares Outstanding
Liabilities And Stockholders Equity
Inventory
Other Current Assets
Other Stockholder Equity
Total Liab
Total Current Assets
Accumulated Other Comprehensive Income
Intangible Assets
Common Stock
Property Plant Equipment
Short Long Term Debt Total
Net Debt
Non Current Liabilities Total
Net Invested Capital
Property Plant And Equipment Gross
Capital Stock
Non Current Liabilities Other
Net Working Capital
Short Term Debt
Retained Earnings
Cash
Capital Lease Obligations
Long Term Debt
Cash And Short Term Investments
Tax Provision
Depreciation And Amortization
Interest Expense
Selling General Administrative
Selling And Marketing Expenses
Total Revenue
Gross Profit
Other Operating Expenses
Operating Income
Net Income From Continuing Ops
Ebit
Research Development
Ebitda
Cost Of Revenue
Total Operating Expenses
Reconciled Depreciation
Income Before Tax
Total Other Income Expense Net
Net Income Applicable To Common Shares
Income Tax Expense
Net Interest Income
Probability Of Bankruptcy
Understanding current and past Embecta Corp Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Embecta Corp's financial statements are interrelated, with each one affecting the others. For example, an increase in Embecta Corp's assets may result in an increase in income on the income statement.
Please note, the presentation of Embecta Corp's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Embecta Corp's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Embecta Corp's management manipulating its earnings.
Embecta Corp Stock Summary
Embecta Corp competes with Baxter International, West Pharmaceutical, ResMed, Cooper Companies,, and ICU Medical. Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. operates independently of Becton, Dickinson and Company as of April 1, 2022. Embecta Corp operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 2000 people.
Comparative valuation techniques use various fundamental indicators to help in determining Embecta Corp's current stock value. Our valuation model uses many indicators to compare Embecta Corp value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Embecta Corp competition to find correlations between indicators driving Embecta Corp's intrinsic value. More Info.
Embecta Corp is rated below average in return on asset category among its peers. It also is rated below average in profit margin category among its peers fabricating about 1.68 of Profit Margin per Return On Asset. At present, Embecta Corp's Net Profit Margin is projected to slightly decrease based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Embecta Corp's earnings, one of the primary drivers of an investment's value.
Embecta Corp's Earnings Breakdown by Geography
Embecta Corp Systematic Risk
Embecta Corp's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Embecta Corp volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on Embecta Corp correlated with the market. If Beta is less than 0 Embecta Corp generally moves in the opposite direction as compared to the market. If Embecta Corp Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Embecta Corp is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Embecta Corp is generally in the same direction as the market. If Beta > 1 Embecta Corp moves generally in the same direction as, but more than the movement of the benchmark.
Embecta Corp Thematic Clasifications
Embecta Corp is part of Medical Equipment investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. USA Equities from Medical Equipment industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions
This theme covers USA Equities from Medical Equipment industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions. Get More Thematic Ideas
Today, most investors in Embecta Corp Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Embecta Corp's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Embecta Corp growth as a starting point in their analysis.
Price Earnings To Growth Ratio
1.11
At present, Embecta Corp's Price Earnings To Growth Ratio is projected to increase based on the last few years of reporting.
Embecta Corp March 20, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Embecta Corp help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Embecta Corp. We use our internally-developed statistical techniques to arrive at the intrinsic value of Embecta Corp based on widely used predictive technical indicators. In general, we focus on analyzing Embecta Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Embecta Corp's daily price indicators and compare them against related drivers.
When running Embecta Corp's price analysis, check to measure Embecta Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Embecta Corp is operating at the current time. Most of Embecta Corp's value examination focuses on studying past and present price action to predict the probability of Embecta Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Embecta Corp's price. Additionally, you may evaluate how the addition of Embecta Corp to your portfolios can decrease your overall portfolio volatility.